Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders)

Publisher： Bentham Science Publishers

Founded in： 2001

Total resources： 51

E-ISSN： 2212-3873

ISSN： 1871-5303

Subject： R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders)

Menu

New Perspectives Regarding Anaplastic Thyroid Carcinoma Approach Improvement

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders) , Vol. 18, Iss. 6, 2018-11 , pp. 555-564

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Non-Alcoholic Fatty Pancreas Disease (NAFPD): A Silent Spectator or the Fifth Component of Metabolic Syndrome? A Literature Review

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders) , Vol. 18, Iss. 6, 2018-11 , pp. 547-554

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Predicting Esophageal Varices in Cirrhotic Hepatitis C Virus Patients Using Noninvasive Measurement of Insulin Resistance Variables

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders) , Vol. 18, Iss. 6, 2018-11 , pp. 573-580

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

The Inhibitory Effect of Some Drugs on Candida rugosa Lipase and Human Pancreatic Lipase: In vitro and In silico Studies

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders) , Vol. 18, Iss. 6, 2018-11 , pp. 602-609

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Serum N-terminal Pro-brain Natriuretic Peptide Level is Associated with the Development of Chronic Kidney Diseases in Patients with Type 2 Diabetes

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders) , Vol. 18, Iss. 6, 2018-11 , pp. 590-595

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Antidiabetic Effect of Spearmint in Streptozotocin-Induced Diabetic Rats

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders) , Vol. 18, Iss. 6, 2018-11 , pp. 581-589

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Bullous Pemphigoid and Neurologic Diseases: Toward a Specific Serologic Profile?

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders) , Vol. 18, Iss. 6, 2018-11 , pp. 662-664

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Successful Treatment for Severe Thyroid-associated Ophthalmopathy with Tocilizumab

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders) , Vol. 18, Iss. 6, 2018-11 , pp. 665-667

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Acknowledgements to Reviewers

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders) , Vol. 18, Iss. 6, 2018-11 , pp. 668-668

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Mechanism by which Regulatory Rheumatoid Factor Prevents Experimental Autoimmune Encephalomyelitis

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders) , Vol. 18, Iss. 6, 2018-11 , pp. 596-601

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Previous 1 2 3 4 5 ... 52 Next Display item(s) per page Total 517 item(s)